J M Smith Corporation v. Novo Nordisk Inc

Court

District Court, E.D. New York (E.D.N.Y)
Official Court Website →

Docket number

1:26-cv-00420

Cause

15:2 Antitrust Litigation
15 U.S.C. § 2 — Sherman Act (monopolization)

Nature of suit

410 Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

01/23/2026

1,069 Antitrust cases in this court are indexed here.

Parties

• plaintiff · J M Smith Corporation · 9 cases
• defendant · Novo Nordisk A/S Pharmaceuticals & Biotechnology · 872 cases

About Antitrust Lawsuits

Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

Frequently Asked Questions

What is J M Smith Corporation v. Novo Nordisk Inc?

J M Smith Corporation v. Novo Nordisk Inc is a federal antitrust lawsuit filed on 01/23/2026 in the District Court, E.D. New York. The case is currently open in the federal court system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What type of case is this?

It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What court is the case in?

The case is in the District Court, E.D. New York, docket number 1:26-cv-00420.

When was the case filed?

J M Smith Corporation v. Novo Nordisk Inc was filed on 01/23/2026. The case is currently open.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 2 — Sherman Act (monopolization).